Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target

Malvina Koni(University of Turin), Maria Felice Brizzi(University of Turin)
Cancers
August 13, 2022
Cited by 12


Related Papers